William W Lockwood

13PUBLICATIONS
46CO-AUTHORS
Computer aided designMolecular targetsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 12, 2026
Pervasive Cas9 expression driven by mammalian promoter activity in E. coli affects representation of CRISPR sgRNA libraries.

|Mar 22, 2026
ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability.

Dylan A Farnsworth, Farhana Naznin, Asha Subramaniam

|May 31, 2025
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Rocky Shi, Dylan A Farnsworth, Christopher A Febres-Aldana

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Jul 08, 2024
Uncovering molecular features driving lung adenocarcinoma heterogeneity in patients who formerly smoked.

Peiyao Wang, Raymond Ng, Stephen Lam

|Jun 18, 2024
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response.

Amy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang

Pageof 3

Frequent Collaborators

2 joint publications

Yibo Xue

2 joint publications

Jordan L Morris

2 joint publications

Kangning Yang

2 joint publications

Leora Witkowski